In a previous controlled trial we reported that 'gut directed' hypnotherapy appeared to be highly effective in the management of patients with severe refractory irritable bowel syndrome.' A criticism of this study has been that the follow up period of three months was too short to discount a placebo response to hypnosis.2' All 15 patients treated with hypnotherapy in the original study have now been followed up for over one year and these data are reported here together with experience on an additional 35 patients treated in a similar manner.
SUMMARY Fifteen patients with severe intractable irritable bowel syndrome previously reported as successfully treated with hypnotherapy, have now been followed up for a mean duration of 18 months. All patients remain in remission although two have experienced a single relapse overcome by an additional session of hypnotherapy. Experience with a further 35 patients is reported giving a total group of 50. This group was divided into classical cases, atypical cases and cases exhibiting significant psychopathology. The response rates were 95%, 43%, and 60% respectively. Patients over the age of 50 years responded very poorly (25%) whereas those below the age of 50 with classical irritable bowel syndrome exhibited a 100% response rate. This study confirms the successful effect of hypnotherapy in a larger series of patients with irritable bowel syndrome and defines some subgroup variations.
In a previous controlled trial we reported that 'gut directed' hypnotherapy appeared to be highly effective in the management of patients with severe refractory irritable bowel syndrome.' A criticism of this study has been that the follow up period of three months was too short to discount a placebo response to hypnosis.2' All 15 patients treated with hypnotherapy in the original study have now been followed up for over one year and these data are reported here together with experience on an additional 35 patients treated in a similar manner.
Methods

PATIENTS
The 15 patients receiving hypnotherapy in the original study have been followed up at three monthly intervals with an assessment of symptom scores and an additional session of hypnotherapy at each visit. The miean follow up period was 18 months (14-21 months). Patients were asked to telephone if they experienced a relapse so that an additional session of hypnotherapy could be arranged. A further 35 patients (31 women, four men, aged 23-65 years) with intractable irritable bowel syndrome have also been treated by hypnotherapy and followed for at least three months. These patients were divided into three groups. Group 1: classical cases of irritable bowel syndrome exhibiting abdominal pain, abdominal distension, and an abnormal bowel habit. Group 2: atypical cases lacking one or two of the three criteria necessary for Group 1. Group 3: patients with classical irritable bowel syndrome with significant psychopathology as judged by a score in excess of 14 on the 28 question general health questionnaire.4 The original study only included patients in Group 1.
Hypnotherapy was carried out 1y PJW and consisted of half hour sessions of decreasing frequency over a three month period. Patients were given a tape for daily autohypnosis after the third session. Before hypnosis the patient was given a simple account of intestinal smooth muscle physiology. Hypnosis was induced by an eye fixation and arm levitation technique followed by standard deepening procedures. After general comments about improvement of health and wellbeing, attention was directed to the control of intestinal smooth muscle. The patient was asked to place his/her hand on the abdomen, feel a sense of warmth and relate this to asserting control over gut function. All sessions were concluded with standard ego strengthening suggestions. No subject was unable to be hypnotised. Ten 
Discussion
This follow up study confirms the longterm efficacy of hypnotherapy in severe irritable bowel syndrome but it is still too early to establish whether the improvement will be permanent. Despite encouragement to continue with regular autohypnosis all patients are still receiving three monthly hypnotherapy because of a clinical impression that this is necessary to maintain remission in some subjects. A controlled study is now in progress to answer this question.
It was felt inappropriate to have a control group for the additional 35 patients reported as our previous controlled trial had shown a clear cut advantage for hypnotherapy. As in the original study the additional patients reported here were all severe cases of irritable bowel syndrome who had proved refractory to conventional forms of therapy and therefore might be expected to have a similar low placebo response.
From the data for the total group of 50 patients it appears that the response to hypnotherapy is dependent on the subject's age. A high success rate was achieved in classical cases (Group 1) under the age of 50 years, which is fortunately the age group The mechanism by which hypnosis exerts its beneficial effect is unclear. We feel that gut directed hypnosis is critically important and this view is supported by the observation that six of the patients reported herein had previously received hypnotherapy of a non-specific nature without any beneficial effect on their irritable bowel syndrome. In order to answer this question conclusively, however, a controlled study is now in progress to compare the effect of hypnotic relaxation with gut directed hypnosis.
In conclusion this additional study confirms the dramatic response of many patients with irritable bowel syndrome to hypnotherapy and helps to define those patients most likely to respond.
SMC is supported by a grant from the North Western Regional Health Authority. 
